Latest Blogs

Jun 25, 2019
As a physician and future pediatric oncologist, Dr. Rachel Offenbacher believes that providers have the responsibility to be vocal about the critical importance of vaccines.
Jun 25, 2019
"We are in a unique moment in terms of the pace of breakthroughs that are being made and the variety of places that breakthroughs are happening," writes Dr. Peter P. Yu.
Jun 25, 2019
We owe it to this vulnerable population to check our assumptions and deliver the highest-quality cancer care in a safe and welcoming environment.
Jun 20, 2019
Key cancer-related topics discussed at the AMA-HOD meeting included alcohol ingestion as a causation risk factor, appropriate guidelines for opioids in the cancer setting, and the use of de-identified patient information.
Subscribe to this column

Julie Vose, MD, MBA, FASCO

Julie M. Vose, MD, MBA, FASCO, is the 2015-2016 President of ASCO. She is the Neumann M. and Mildred E. Harris Professorial Chair and Chief of the Oncology/Hematology Division in the Department of Internal Medicine at the University of Nebraska Medical Center. She is also the Associate Director of Clinical Research at the Fred and Pamela Buffett Cancer Center.

In addition to being ASCO President, Dr. Vose also serves on the Special Awards Selection and Health Disparities Committees. An ASCO member since 1991, Dr. Vose has served on the Board of Directors, Nominating Committee, Scientific Program Committee, Hematology-Oncology Task Force, Cancer.Net Advisory Panel and Editorial Board, and Journal of Clinical Oncology Editorial Board. She served as Chair of the Cancer Education Committee and Publications Committee. Follow Dr. Vose on Twitter at @DrJulieVose.

Mar 23, 2016
Dr. Hudis will assume the role of ASCO and Conquer Cancer Foundation CEO on June 27, following the retirement of Dr. Allen Lichter.
Mar 15, 2016
This year’s report clearly shows that strengthening the delivery system for cancer care has to be pursued just as aggressively as its research agenda.
Feb 11, 2016
The American Board of Internal Medicine (ABIM) invited all ABIM-certified physicians to participate in a review of the blueprints that outline content areas for subspecialty Maintenance of Certification (MOC) exams.
Jan 29, 2016
In the face of limited health care resources and a rising national health budget, it is important to consider value when making treatment decisions for patients with cancer. This is a key question for all of us involved in cancer care and research. The answer may be a bit different coming from the...
Jan 21, 2016
During the 2016 ASCO Annual Meeting, a new award will be given out to recognize an extraordinary female leader in oncology and role model who has excelled as a mentor. I encourage you to nominate colleagues for this honor by January 29.
Nov 17, 2015
The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), which passed earlier this year, repealed the fundamentally flawed Sustainable Growth Rate formula and introduced significant changes in how Medicare will pay oncologists for the care they provide in the coming years.

Pages